JPH11103832A - Production of dandelion tea leaf, dandelion tea leaf and antiviral agent - Google Patents
Production of dandelion tea leaf, dandelion tea leaf and antiviral agentInfo
- Publication number
- JPH11103832A JPH11103832A JP9260029A JP26002997A JPH11103832A JP H11103832 A JPH11103832 A JP H11103832A JP 9260029 A JP9260029 A JP 9260029A JP 26002997 A JP26002997 A JP 26002997A JP H11103832 A JPH11103832 A JP H11103832A
- Authority
- JP
- Japan
- Prior art keywords
- dandelion
- leaves
- tea
- raw
- tea leaf
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Tea And Coffee (AREA)
- Non-Alcoholic Beverages (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明はタンポポ茶葉の製造方
法、タンポポ茶葉、に関し、特に、抗ウイルス効果を呈
するタンポポ茶葉に関するものである。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a method for producing dandelion tea leaves, dandelion tea leaves, and more particularly to dandelion tea leaves exhibiting an antiviral effect.
【0002】[0002]
【従来技術とその課題】従来からタンポポの根を加工し
たタンポポ茶が機能性食品として良く知られているが、
生タンポポの葉が薬効を示すことに関する資料は未だ見
いだすことはできず、従って当然生タンポポの葉を利用
した薬品あるいは機能性食品は未だ開発されていない。2. Description of the Related Art Dandelion tea obtained by processing dandelion roots has been well known as a functional food.
No data on the medicinal properties of raw dandelion leaves has yet been found, and, of course, no drug or functional food utilizing raw dandelion leaves has yet been developed.
【0003】また、抗ウイルス効果を呈する薬品として
は例えばウエルカム社の商品名アシクロビルが市販され
ている。しかしながらこのアシクロビルを始めとする抗
ウイルス剤は副作用が強く適用の量や期間に制限をうけ
るとともに、価格的なデメリットも大きい。[0003] As a drug having an antiviral effect, for example, Acyclovir (trade name) manufactured by Welcome Inc. is commercially available. However, antiviral agents such as acyclovir have strong side effects and are limited in the amount and period of application, and are also disadvantageous in terms of price.
【0004】本発明は上記の事情に鑑みて提案されたも
のであって、抗ウイルス効果等の種々の薬効を示すとと
もに安価なタンポポ茶葉を提供することを目的とするも
のである。The present invention has been proposed in view of the above circumstances, and has as its object to provide an inexpensive dandelion tea leaf that exhibits various medicinal effects such as antiviral effects.
【0005】[0005]
【課題を解決するための手段】本発明は上記目的を達成
するために以下の方法を採用している。すなわち、生タ
ンポポ葉を60〜80℃で10〜20分程度蒸気で蒸し
た後、30〜50℃で乾燥させてタンポポ茶葉を得たも
のである。The present invention employs the following method to achieve the above object. That is, raw dandelion leaves are steamed at 60 to 80 ° C. for about 10 to 20 minutes, and then dried at 30 to 50 ° C. to obtain dandelion tea leaves.
【0006】このタンポポ茶葉はこのままお茶として使
用することもできるが、苦みを抑える必要があることか
ら、上記タンポポ茶葉85〜98%、に粉末沙苑子2〜
15%を添加することも可能である。Although this dandelion tea leaf can be used as it is as tea, it is necessary to suppress bitterness.
It is also possible to add 15%.
【0007】更に、必要に応じて緑茶、紅茶の中のいず
れか一方、あるいは両方を添加することも可能である。
更にこのタンポポ茶葉は抗ウイルス剤としての効果を発
揮する。タンポポ茶葉をそのまま服用、あるいは茶とし
て飲用しても当然抗ウイルス効果を得ることができる
が、タンポポ茶葉を水で煮沸した後、水分を蒸発させて
得たタンポポ茶エキスが有効である。[0007] If necessary, one or both of green tea and black tea can be added.
Furthermore, this dandelion tea leaf exhibits an effect as an antiviral agent. The antiviral effect can be naturally obtained by taking dandelion tea leaves as they are or drinking them as tea. However, dandelion tea extracts obtained by boiling dandelion tea leaves with water and evaporating the water are effective.
【0008】[0008]
(実施例1)まず、清浄な生タンポポ葉を60〜80℃
で10〜20分程度蒸気で蒸した後、30〜50℃で充
分乾燥させた後粉砕してタンポポ茶葉を得た。生タンポ
ポ葉としては、関東タンポポ、関西タンポポ、西洋タン
ポポのいずれも使用可能である。(Example 1) First, clean raw dandelion leaves are heated to 60 to 80 ° C.
After steaming with steam for about 10 to 20 minutes, the mixture was sufficiently dried at 30 to 50 ° C. and then pulverized to obtain dandelion tea leaves. As raw dandelion leaves, any of Kanto dandelion, Kansai dandelion, and western dandelion can be used.
【0009】上記のタンポポ茶葉をそのまま使用して茶
飲料にすることができるが、苦みをともなうことから、
通常の茶として使用する場合には、更に、粉末沙苑子2
〜15%を添加し、更に、必要に応じて緑茶、紅茶の中
のいずれか一方、あるいは両方を味付け材として添加す
る。The above dandelion tea leaves can be used as they are to make tea beverages, but because of the bitterness,
When used as normal tea, add
-15%, and if necessary, one or both of green tea and black tea as a seasoning.
【0010】沙苑子は中国の遼寧、吉林、河北、陜西、
内モンゴルに自生するマメ化の多年草である。この沙苑
子の乾燥した成熟種子を60〜80℃で充分程炒めた後
粉砕することによって粉末沙苑子が得られる。Shayuanzi is located in Liaoning, Jilin, Hebei, Shaanxi, China.
It is a perennial bean that grows naturally in Inner Mongolia. The dried mature seeds of Saenko are thoroughly fried at 60-80 ° C and then ground to obtain powdered Saenko.
【0011】[0011]
【表1】 [Table 1]
【0012】(実施例2)上記のように配合したタンポ
ポ茶葉2gを500ccの水で5分間煮立てて得た茶飲
料を1日分として、各種ヘルペスの患者に飲ませた結果
を表2に示す。(Example 2) Table 2 shows the results obtained when 2 g of dandelion tea leaves blended as described above were boiled in 500 cc of water for 5 minutes to give a day of tea drink to various herpes patients. .
【0013】[0013]
【表2】 [Table 2]
【0014】(実施例3)表3は本願タンポポエキスと
ウエルカム社のアシクロビルとの比較をCPEで表した
ものである。CPE(細胞変質効果)は通常細胞の円形
膨潤化を意味し、ベロ細胞にHSV−1(単純ヘルペス
ウイルス)100個を植えつけて2日間培養した場合の
各培養液に対して所定量のタンポポエキスを添加した
場合と、所定量のアシクロビルを添加した場合、更に
培養液のみの場合の3様で比較した。(Example 3) Table 3 shows the comparison between the dandelion extract of the present invention and acyclovir of Welcome, expressed in CPE. CPE (cell degeneration effect) usually means circular swelling of cells, and a predetermined amount of dandelion is used for each culture when 100 cells of HSV-1 (herpes simplex virus) are inoculated in Vero cells and cultured for 2 days. Three comparisons were made between the case where the extract was added, the case where a predetermined amount of acyclovir was added, and the case where only the culture solution was used.
【0015】タンポポエキスは後述するようにタンポポ
茶葉を30分〜1時間程度水で煮沸し、煮出し液を凍結
乾燥して得た固形分であり、原料5に対して1の割合で
得られる。同じ濃度のアシクロビルと比較した場合はア
シクロビルの方が効果が大きいが、価格的なメリットは
タンポポエキスの方が遙に大きいことが理解できる。The dandelion extract is a solid content obtained by boiling dandelion tea leaves with water for about 30 minutes to 1 hour and freeze-drying the boiled liquid as described later. It can be understood that acyclovir is more effective when compared with acyclovir of the same concentration, but that the dandelion extract has a far greater cost advantage.
【0016】[0016]
【表3】 [Table 3]
【0017】(実施例4)更に表4はマウスに2.5×
105 /0.1mLのHSV−1ウイルス(単純ヘルペ
スウイルス)を接種し、食塩水とタンポポエキスを経口
投与した場合の生存日数を示すものである。(Example 4) Further, Table 4 shows that 2.5 ××
10 shows the survival days when inoculated with 10 5 /0.1 mL of HSV-1 virus (herpes simplex virus) and orally administered saline and dandelion extract.
【0018】[0018]
【表4】 [Table 4]
【0019】この表からも理解できるように、タンポポ
エキスの摂取量が多い程、生存率が高くなる。 (実施例5)また、表5は14才から35才までの女性
500人に表1に説明した方法で作った茶を用いて、タ
ンポポ茶による乳腺の発育促進効果を示した結果のバス
トのサイズの統計を示すものである。尚、タンポポ茶は
実施例2に記述した製法で作り、また、一日分の量とし
て500gを基準とした。As can be seen from this table, the higher the intake of dandelion extract, the higher the survival rate. (Example 5) Table 5 shows the effect of dandelion tea on the growth promotion of the mammary gland by dandelion tea using the tea prepared by the method described in Table 1 for 500 women aged 14 to 35 years. It shows size statistics. The dandelion tea was prepared by the method described in Example 2, and the amount per day was set at 500 g.
【0020】[0020]
【表5】 [Table 5]
【0021】(実施例6)図1は肝炎患者でタンポポ
茶を使用した者200人、肝炎患者でタンポポ茶を使
用しない者150人、健常者560人に対して毎日所
定量のタンポポ茶を飲ませた結果を示すののである。G
TPが当初120前後あった者も12カ月で100を下
回る値となっている。更に、2年を経過すると健常者と
全く変わりなくなっていることが理解できる。尚、タン
ポポ茶は実施例2に記述した製法で作り、また、一日分
の量として500gを基準とした。EXAMPLE 6 FIG. 1 shows that 200 hepatitis patients who used dandelion tea, 150 hepatitis patients who did not use dandelion tea, and 560 healthy people drink a predetermined amount of dandelion tea every day. It shows the results that have been missed. G
Those who initially had a TP of around 120 are below 100 in 12 months. Furthermore, it can be understood that after two years, it is no different from a healthy person. The dandelion tea was prepared by the method described in Example 2, and the amount per day was set at 500 g.
【0022】(エキスの製造)タンポポエキスは通常の
エキスの製造方法によって製造することができるが、例
えば以下の例を挙げることができる。(Manufacture of extract) Dandelion extract can be manufactured by a usual extract manufacturing method.
【0023】乾燥タンポポ葉を粉砕して4〜18メッ
シュの篩にかける。 上記原料50kgを1000Lの水で95〜100℃
で1時間煮沸する。 上記液を最初に50メッシュの金網、ついで200メ
ッシュの濾布で濾して約800Lの濾液を得る。The dried dandelion leaves are ground and sieved through a 4-18 mesh sieve. 50 kg of the above raw material is 95 to 100 ° C. with 1000 L of water.
And boil for 1 hour. The above solution is first filtered through a 50-mesh wire gauze and then through a 200-mesh filter cloth to obtain about 800 L of filtrate.
【0024】100mgHgの減圧下、50℃の温度
の下で6時間濃縮して約40Lの濃縮液を得る。 次いで粉霧乾燥あるいは凍結乾燥処理をする。Concentration is performed under a reduced pressure of 100 mgHg at a temperature of 50 ° C. for 6 hours to obtain about 40 L of a concentrated liquid. Next, a spray drying or freeze drying treatment is performed.
【0025】得られた粉状エキスの中、粉径の粗いも
のは更に粉砕して最後に30〜50メッシュの篩で粉径
を揃えることによって約10kgのエキスを得る。Among the obtained powdery extracts, those having a coarse powder diameter are further pulverized and finally the powder diameter is made uniform with a 30 to 50 mesh sieve to obtain about 10 kg of the extract.
【0026】[0026]
【発明の効果】以上説明したように、本発明は安価なタ
ンポポを原料とするにもかかわらず、優れた抗ウイルス
効果を示す他、肝炎にも優れた効果を示し、更に、乳腺
の発育効果も得ることができる。As described above, the present invention exhibits excellent antiviral effects, in spite of using inexpensive dandelions as a raw material, exhibits excellent effects on hepatitis, and furthermore, has a mammary gland development effect. Can also be obtained.
Claims (10)
0分程度蒸気で蒸した後、30〜50℃で乾燥させたこ
とを特徴とするタンポポ茶葉の製造方法。1. Raw dandelion leaves at 60-80 ° C. for 10-2
A method for producing dandelion tea leaves, comprising steaming with steam for about 0 minutes and drying at 30 to 50 ° C.
0分程度蒸気で蒸した後、30〜50℃で乾燥させたこ
とを特徴とするタンポポ茶葉。2. Raw dandelion leaves at 60-80 ° C. for 10-2.
A dandelion tea leaf, which is steamed for about 0 minutes and then dried at 30 to 50 ° C.
子2〜15%を添加した請求項2に記載のタンポポ茶
葉。3. The dandelion tea leaves according to claim 2, wherein 85 to 98% of dandelion tea leaves and 2 to 15% of powdered soybean powder are added.
ずれか一方、あるいは両方を添加した請求項2または3
のいずれかに記載のタンポポ茶葉。4. The method according to claim 2, wherein one or both of green tea and black tea are added as required.
The dandelion tea leaf according to any one of the above.
剤。5. An antiviral agent obtained by drying raw dandelion leaves.
0分程度蒸気で蒸した後、30〜50℃で乾燥させた請
求項5に記載の項ウイルス剤。6. Fresh dandelion leaves at 60-80 ° C. for 10-2.
The virus agent according to claim 5, wherein the agent is steamed for about 0 minutes and then dried at 30 to 50 ° C.
乾燥させて得たタンポポ茶葉を水で煮沸した煮出し液の
水分を蒸発させてエキス状とした抗ウイルス剤。7. An antiviral agent in which raw dandelion leaves or dandelion tea leaves obtained by drying raw dandelion leaves are boiled in water to obtain an extract in the form of an extract by evaporating the water content.
0分程度蒸気で蒸した後、30〜50℃で乾燥させた上
記タンポポ茶葉を使用する請求項7に記載の抗ウイルス
剤。8. Raw dandelion leaves at 60-80 ° C. for 10-2
The antiviral agent according to claim 7, wherein the dandelion tea leaves which have been steamed for about 0 minutes and dried at 30 to 50 ° C are used.
乾燥させて得たタンポポ茶葉より主要成分をアルコール
抽出してエキス状とした抗ウイルス剤。9. An antiviral agent in which the main component is extracted from raw dandelion leaves or dandelion tea leaves obtained by drying the raw dandelion leaves with alcohol to form an extract.
20分程度蒸気で蒸した後、30〜50℃で乾燥させた
上記タンポポ茶葉を使用する請求項9に記載の抗ウイル
ス剤。10. Raw dandelion leaves at 60-80 ° C.
The antiviral agent according to claim 9, wherein the dandelion tea leaves which have been steamed for about 20 minutes and then dried at 30 to 50 ° C are used.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9260029A JPH11103832A (en) | 1997-09-25 | 1997-09-25 | Production of dandelion tea leaf, dandelion tea leaf and antiviral agent |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9260029A JPH11103832A (en) | 1997-09-25 | 1997-09-25 | Production of dandelion tea leaf, dandelion tea leaf and antiviral agent |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH11103832A true JPH11103832A (en) | 1999-04-20 |
Family
ID=17342323
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP9260029A Pending JPH11103832A (en) | 1997-09-25 | 1997-09-25 | Production of dandelion tea leaf, dandelion tea leaf and antiviral agent |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH11103832A (en) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1088336C (en) * | 2000-06-30 | 2002-07-31 | 李选铭 | Process for preparing health-care dandelion tea |
CN103330035A (en) * | 2013-07-16 | 2013-10-02 | 海伦野泰食品加工有限公司 | Preparation method of dandelion tea |
KR101403354B1 (en) * | 2012-10-16 | 2014-06-05 | 천상욱 | Method for producing beverage using dandelion |
KR101403355B1 (en) * | 2012-10-16 | 2014-06-05 | 천상욱 | Method for producing dandelion flower Sikhae |
JP2017517543A (en) * | 2014-06-11 | 2017-06-29 | イクセラ,インコーポレイテッド | Treatment of viral skin diseases |
CN107683931A (en) * | 2017-09-27 | 2018-02-13 | 田光 | A kind of black nightshade tea and preparation method thereof |
CN108782908A (en) * | 2018-09-05 | 2018-11-13 | 安顺市平坝区十字乡十字村上坝种植场 | A kind of processing technology of pure dandelion herb tea |
CN109275760A (en) * | 2018-10-23 | 2019-01-29 | 长春大学 | The preparation method of dandelion function tea |
CN112335809A (en) * | 2019-08-08 | 2021-02-09 | 海南鑫禾生物工程有限公司 | Dandelion drying process |
US11041847B1 (en) | 2019-01-25 | 2021-06-22 | Ixcela, Inc. | Detection and modification of gut microbial population |
KR102524088B1 (en) * | 2022-10-27 | 2023-04-21 | 한국 한의학 연구원 | Composition for preventing, ameliorating or treating coronavirus infectious disease comprising herbal medicine extract as effective component |
-
1997
- 1997-09-25 JP JP9260029A patent/JPH11103832A/en active Pending
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1088336C (en) * | 2000-06-30 | 2002-07-31 | 李选铭 | Process for preparing health-care dandelion tea |
KR101403354B1 (en) * | 2012-10-16 | 2014-06-05 | 천상욱 | Method for producing beverage using dandelion |
KR101403355B1 (en) * | 2012-10-16 | 2014-06-05 | 천상욱 | Method for producing dandelion flower Sikhae |
CN103330035A (en) * | 2013-07-16 | 2013-10-02 | 海伦野泰食品加工有限公司 | Preparation method of dandelion tea |
JP2017517543A (en) * | 2014-06-11 | 2017-06-29 | イクセラ,インコーポレイテッド | Treatment of viral skin diseases |
CN107683931A (en) * | 2017-09-27 | 2018-02-13 | 田光 | A kind of black nightshade tea and preparation method thereof |
CN108782908A (en) * | 2018-09-05 | 2018-11-13 | 安顺市平坝区十字乡十字村上坝种植场 | A kind of processing technology of pure dandelion herb tea |
CN109275760A (en) * | 2018-10-23 | 2019-01-29 | 长春大学 | The preparation method of dandelion function tea |
US11041847B1 (en) | 2019-01-25 | 2021-06-22 | Ixcela, Inc. | Detection and modification of gut microbial population |
US11287418B2 (en) | 2019-01-25 | 2022-03-29 | Ixcela, Inc. | Detection and modification of gut microbial population |
US11287419B2 (en) | 2019-01-25 | 2022-03-29 | Ixcela, Inc. | Detection and modification of gut microbial population |
US11287417B2 (en) | 2019-01-25 | 2022-03-29 | Ixcela, Inc. | Detection and modification of gut microbial population |
US11287420B2 (en) | 2019-01-25 | 2022-03-29 | Ixcela, Inc. | Detection and modification of gut microbial population |
CN112335809A (en) * | 2019-08-08 | 2021-02-09 | 海南鑫禾生物工程有限公司 | Dandelion drying process |
KR102524088B1 (en) * | 2022-10-27 | 2023-04-21 | 한국 한의학 연구원 | Composition for preventing, ameliorating or treating coronavirus infectious disease comprising herbal medicine extract as effective component |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105725200A (en) | Processing method for soluble dendrobium officinale freeze-dried powder | |
JPH11103832A (en) | Production of dandelion tea leaf, dandelion tea leaf and antiviral agent | |
CN102726580A (en) | Lucid ganoderma tea, lucid ganoderma teabag and processing technology thereof | |
KR101060309B1 (en) | Restorative herb medicine with jujube and manufacturing method thereof | |
KR101845297B1 (en) | Manufacturing method of Syrup using Eutteumbaek Platycodon and Syrup using Eutteumbaek Platycodon manufactured by the same | |
KR20130121324A (en) | Composition for preventing and treating hangover comprising extracts of leaves of perilla frutescens britton var | |
KR20130106979A (en) | Process for preparing fermented power tea from unpolished rice and guava leaves | |
KR101867480B1 (en) | Manufacturing method of the extract with Glehnia littoralis for food | |
CN106109569A (en) | A kind of production method of Spica Prunellae beverage particles | |
EP1968401B1 (en) | Functional food composition for treating allergy, natural tea using the same and the manufacturing method thereof | |
WO2019184308A1 (en) | Blood fat-reducing and blood pressure-reducing health care tea and preparation method therefor | |
KR101894994B1 (en) | Method for Preparing Mulberry Leaf Extracts | |
CN104824255A (en) | Instant-dissolving chrysanthemum and Pu'er tea extract | |
KR101968891B1 (en) | Composition for treating hangover comprising extracts of fruits of stauntonia hexaphylla | |
CN104352477A (en) | Traditional Chinese medicine pain-relieving capsule and preparation method thereof | |
CN104719534A (en) | Anti-aging tea bag and preparation method thereof | |
CN105724650A (en) | Polygonatum sibiricum powder tea and production method thereof | |
KR102362034B1 (en) | Functional salad dressing and manufacturing method thereof | |
CN100429984C (en) | Method for preparing ginseng bag tea | |
KR102568831B1 (en) | Manufacturing Method of Wild Ginseng Syrup | |
KR102404179B1 (en) | Preparing method of jujube tea | |
KR101509909B1 (en) | Sikhye comprising the extracts of achyranthes radix and manufacturing methods thereof | |
CN103719502B (en) | A kind of metapanax of araliaceae prepares the method for tealeaves | |
CN108850361B (en) | Preparation method of mint instant tea | |
CN109566929B (en) | Preparation method of dandelion health-care beverage |